1. Home
  2. CVAC vs GSBC Comparison

CVAC vs GSBC Comparison

Compare CVAC & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • GSBC
  • Stock Information
  • Founded
  • CVAC 2000
  • GSBC 1923
  • Country
  • CVAC Germany
  • GSBC United States
  • Employees
  • CVAC N/A
  • GSBC N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • GSBC Major Banks
  • Sector
  • CVAC Health Care
  • GSBC Finance
  • Exchange
  • CVAC Nasdaq
  • GSBC Nasdaq
  • Market Cap
  • CVAC 764.4M
  • GSBC 665.7M
  • IPO Year
  • CVAC 2020
  • GSBC N/A
  • Fundamental
  • Price
  • CVAC $5.40
  • GSBC $61.87
  • Analyst Decision
  • CVAC Hold
  • GSBC Hold
  • Analyst Count
  • CVAC 3
  • GSBC 2
  • Target Price
  • CVAC $6.83
  • GSBC $59.50
  • AVG Volume (30 Days)
  • CVAC 2.1M
  • GSBC 77.9K
  • Earning Date
  • CVAC 08-14-2025
  • GSBC 07-16-2025
  • Dividend Yield
  • CVAC N/A
  • GSBC 2.63%
  • EPS Growth
  • CVAC N/A
  • GSBC 10.52
  • EPS
  • CVAC 0.87
  • GSBC 5.60
  • Revenue
  • CVAC $566,039,775.00
  • GSBC $219,572,000.00
  • Revenue This Year
  • CVAC N/A
  • GSBC N/A
  • Revenue Next Year
  • CVAC $24.04
  • GSBC $1.04
  • P/E Ratio
  • CVAC $6.22
  • GSBC $10.88
  • Revenue Growth
  • CVAC 787.60
  • GSBC N/A
  • 52 Week Low
  • CVAC $2.37
  • GSBC $47.58
  • 52 Week High
  • CVAC $5.72
  • GSBC $68.02
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 64.78
  • GSBC 71.19
  • Support Level
  • CVAC $5.33
  • GSBC $58.58
  • Resistance Level
  • CVAC $5.58
  • GSBC $60.00
  • Average True Range (ATR)
  • CVAC 0.12
  • GSBC 1.39
  • MACD
  • CVAC -0.04
  • GSBC 0.51
  • Stochastic Oscillator
  • CVAC 23.81
  • GSBC 98.29

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.

Share on Social Networks: